Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Pinterest Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Pinterest Inc trades at $21.59 (market cap $12.67B). The key difference: Pinterest Inc is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Pinterest Inc for 85 Days on average.
| KYMR | PINS | |
|---|---|---|
Market Cap | $8.87B | $12.67B |
Volume | 779,107 | 12,391,118 |
Sector | Health | Media |
52-Week High | $127.31 | $35.24 |
52-Week Low | $55.80 | $15.42 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $8.26B | $12.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pinterest (PINS) trades at $21.76, up 1.56% today, with a bullish technical signal from moving averages and strong recent earnings beats. Revenue has grown from $2.8B in 2022 to $4.2B in 2025, though net income margin is modest at 5.46%. The company continues to innovate with new ad products like Visual Search Ads, enhancing its advertising moat. Analyst consensus is bullish with a $27.93 price target, but high valuation ratios and insider selling present cautionary notes.
The outlook for PINS is positive given consistent revenue growth and strategic ad initiatives, offering potential upside to the consensus target. However, risks include elevated P/E of 65.79, competitive pressures in social media advertising, and negative net cash flow trends. Investors should weigh strong fundamentals against valuation concerns and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
